Evidence map›Paper›PMID 31427690›Full record

ArticleScientific reports2019

Severe Fever with Thrombocytopenia Syndrome Phlebovirus causes lethal viral hemorrhagic fever in cats.

Eun-Sil Park, Masayuki Shimojima, Noriyo Nagata, Yasushi Ami, Tomoki Yoshikawa, Naoko Iwata-Yoshikawa, Shuetsu Fukushi, Shumpei Watanabe, Takeshi Kurosu, Michiyo Kataoka and 9 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 1 pooled it
8.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 1 synthesis or guideline pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Transboundary and emerging diseases · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The public health threat of emerging phenuiviruses.One health (Amsterdam, Netherlands) · 2025
    Review
  18. Article
  19. Article
  20. Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 1 country.

Eun-Sil ParkDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan.
Masayuki ShimojimaDepartment of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan.
Noriyo NagataDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Yasushi AmiDivision of Experimental Animal Research, National Institute of Infectious Diseases, Tokyo, Japan.
Tomoki YoshikawaDepartment of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan.
Naoko Iwata-YoshikawaDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Shuetsu FukushiDepartment of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan.
Shumpei WatanabeDepartment of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan.
Takeshi KurosuDepartment of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan.
Michiyo KataokaDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Akiko OkutaniDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan.
Masanobu KimuraDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan.
Koichi ImaokaDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan.
Kenichi HanakiDivision of Experimental Animal Research, National Institute of Infectious Diseases, Tokyo, Japan.
Tadaki SuzukiDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.ORCID http://orcid.org/0000-0002-3820-9542
Hideki HasegawaDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Masayuki SaijoDepartment of Virology 1, National Institute of Infectious Diseases, Tokyo, Japan.
Ken MaedaLaboratory of Veterinary Microbiology, Yamaguchi University, Yamaguchi, Japan.
Shigeru MorikawaDepartment of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan. morikawa@nih.go.jp.
National Institute of Infectious Diseases · JPYamaguchi University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging hemorrhagic fever caused by the SFTS phlebovirus (SFTSV). SFTS patients were first reported in China, followed by Japan and South Korea. In 2017, cats were diagnosed with SFTS for the first time, suggesting that these animals are susceptible to SFTSV. To confirm whether or not cats were indeed susceptible to SFTSV, animal subjects were experimentally infected with SFTSV. Four of the six cats infected with the SPL010 strain of SFTSV died, all showing similar or more severe symptoms than human SFTS patients, such as a fever, leukocytopenia, thrombocytopenia, weight loss, anorexia, jaundice and depression. High levels of SFTSV RNA loads were detected in the serum, eye swab, saliva, rectal swab and urine, indicating a risk of direct human infection from SFTS-infected animals. Histopathologically, acute necrotizing lymphadenitis and hemophagocytosis were prominent in the lymph nodes and spleen. Severe hemorrhaging was observed throughout the gastrointestinal tract. B cell lineage cells with MUM-1 and CD20, but not Pax-5 in the lesions were predominantly infected with SFTSV. The present study demonstrated that cats were highly susceptible to SFTSV. The risk of direct infection from SFTS-infected cats to humans should therefore be considered.

Indexed as

AnimalsBiomarkersBiopsyCat DiseasesCatsDisease SusceptibilityHemorrhagic Fevers, ViralPhlebovirusSymptom AssessmentBiomarkers

Identifiers

PMID31427690
PMCPMC6700174
OpenAlexW2969469535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.